Paeoniflorin Potentiates the Inhibitory Effects of Erlotinib in Pancreatic Cancer Cell Lines by Reducing ErbB3 Phosphorylation
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Paeoniflorin Potentiates the Inhibitory Effects of Erlotinib in Pancreatic Cancer Cell Lines by Reducing ErbB3 Phosphorylation
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-09-09
DOI
10.1038/srep32809
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models
- (2015) Gaëlle Thomas et al. Oncotarget
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
- (2014) Carlos L. Arteaga et al. CANCER CELL
- Targeting of erbB3 receptor to overcome resistance in cancer treatment
- (2014) Jian Ma et al. Molecular Cancer
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- The ErbB/HER family of protein-tyrosine kinases and cancer
- (2013) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Targeting EGFR in Pancreatic Cancer Treatment
- (2012) T. Troiani et al. CURRENT DRUG TARGETS
- Paeoniflorin inhibits growth of human colorectal carcinoma HT 29 cells in vitro and in vivo
- (2012) He Wang et al. FOOD AND CHEMICAL TOXICOLOGY
- Clinical development of insulin-like growth factor receptor—1 (IGF-1R) inhibitors: At the crossroad?
- (2012) Andrea Gombos et al. INVESTIGATIONAL NEW DRUGS
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Modulating Bcl-2 Family Proteins and Caspase-3 in Induction of Apoptosis by Paeoniflorin in Human Cervical Cancer Cells
- (2011) Lili Zhang et al. PHYTOTHERAPY RESEARCH
- HER-3 Overexpression Is Prognostic of Reduced Breast Cancer Survival
- (2010) Connie G. Chiu et al. ANNALS OF SURGERY
- Clinical Development of Inhibitors of the Insulin-like Growth Factor Receptor in Oncology
- (2009) Antonio Gualberto et al. CURRENT DRUG TARGETS
- Paeoniflorin suppress NF-κB activation through modulation of IκBα and enhances 5-fluorouracil-induced apoptosis in human gastric carcinoma cells
- (2008) Hao Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- ANTIPROLIFERATIVE ACTIVITY OF AUCUBIN IS THROUGH CELL CYCLE ARREST AND APOPTOSIS IN HUMAN NON-SMALL CELL LUNG CANCER A549 CELLS
- (2008) Jen-Yu Hung et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started